Search clinical trials for: PF-06751979 multiple dose
Total 0 results
Nothing found
Sponsors and Collaborators
- Jeffrey Rudolph
- European Network For Smoking and Tobacco Prevention
- Wushan County People's Hospital
- New York State Health Foundation
- CTC Bio, Inc.
- The Third Hospital of Changsha
- Jeffrey W. Clark, MD
- Ionis Pharmaceuticals
- Marilia Medicine School
- Rex Bionics Plc
- Montreal Neurological Institute and Hospital
- MingSight Pharmaceuticals Pty Limited
- Kawin Technology Share-holding Co., Ltd.
- Health Parametrics Inc.
- Medtronic Atrial Fibrillation Solutions
- Honda R and D Americas, Inc.
- Mitchell Scheiman
- Zahra Rabbani Khah
- John Granton
- Northern California Melanoma Center
- View Full List
Medical Conditions
- HDT-AHCT
- Periferal Arterial Occlusive Disease, PAOD
- Pancreatic Neoplasms
- Primary Generalized Dystonia
- Pregnancy-Related Condition, Unspecified
- Renal Cancer Metastatic
- Brain MRI
- Advanced Esophageal Cancers
- H.Pylori Infection
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- LSIL
- Hyperthyroidism, Autoimmune
- ACTH-Secreting Pituitary Adenoma
- Waldenstrom's Macroglobulinemia Recurrent
- Locally Advanced NSCLC
- Fasting, Diet, Chemotherapy, Toxicity
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Liver Hemangioma
- Metastatic Spine Lesions
- Ascaris Suum
- View Full List
Drug Interventions
- 200 µg doxorubicin-containing MNA
- Nimotuzumab
- Ombrabulin (AVE8062)
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Levobupivacaine, clonidine
- Pentostatin
- Bendamustine
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Levcromakalim
- CKD-519
- Postoperative analgesia management
- Rifaximin
- ESK981
- AZD7798
- Toripalimab plus Anlotinib
- Hydroxychloroquine
- Fludarabine
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- 5-Fluoro-3-Pyridinecarboxylic Acid
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Algeria
- Contract Research Organizations in Chile
- Contract Research Organizations in Denmark
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Egypt
- Contract Research Organizations in Estonia
- Contract Research Organizations in Gambia
- Contract Research Organizations in Italy
- Contract Research Organizations in Liberia
- Contract Research Organizations in Mali
- Contract Research Organizations in Moldova
- Contract Research Organizations in Peru
- CRO list by country